200,000+ products from a single source!

sales@angenechem.com

Home > New 1,2,4-Oxadiazole Nortopsentin Derivatives with Cytotoxic Activity

New 1,2,4-Oxadiazole Nortopsentin Derivatives with Cytotoxic Activity

 

 

Introduction
Natural products (NP) constitute a significant source of bioactive molecules and potential drug leads due to their high chemical diversity, biochemical specificity, binding efficiency with biological targets, and broad panel of bioactivities. About 60% of drugs currently on the market are of natural origin and natural products screening still plays a fundamental role in the drug discovery process [1]. Marine natural products (MNP), in particular marine sponge-derived compounds, have attracted considerable attention due to their unique biodiversity and structural differences as compared to terrestrial natural products. Among MNP or marine-derived molecules, eight compounds are currently on the market with application in different therapeutic areas and several compounds are in different phases of the clinical pipeline, showing promising anticancer activity. Only a few of them are original MNPs, while the majority are derivatives obtained through molecular lead optimization [2].
Considering the successful results obtained using MNP as leads for drug discovery and the growing number of marine-derived molecules entering into clinical trials, researchers are still inspired by their scaffold for the design of new active molecules.


Among MNPs used as lead compounds for the synthesis of new anticancer agents, nortopsentin, an alkaloid isolated from deep-sea sponge Spongsorites ruetzleri having a characteristic 2,4-bis(3'-indolyl)imidazole skeleton, attracted remarkable attention due to its significant antiproliferative activity against the P388 murine leukemia cell line [3]. Many derivatives in which the central imidazole ring was replaced by several five-membered heterocycles were reported, most of them showing antiproliferative activity, often reaching GI50 values in the low micromolar range or even at the sub-micromolar level [3-12]. The thiazole nortopsentin analogs in particular, in which the structural modification of the lead natural molecule also involved one or both indole portions, led to potent compounds with effect against a wide range of cell lines, including diffuse malignant peritoneal mesothelioma (DMPM), a fatal disease, poorly responsive to conventional therapies, and acted as CDK1 inhibitors [13-16]. Moreover, the most active thiazole derivatives also bearing a 7-azaindole substitution, in the mouse model, by intraperitoneal administration were effective with a significant reduction of the DMPM and two complete responses at well-tolerated doses [13].

 

On the other hand, the 1,2,4-oxadiazole ring system is a five-membered heterocycle ring found in many molecules with significant biological activity, especially antitumor [17-19], despite its uncommon presence in MNP, To the best of our knowledge, phidianidines, isolated from the marine opisthobranch mollusk Phidiana militaris, are a unique example of MNP possessing a 1,2,4-oxadiazole ring system in their structure, and together with their derivatives they exhibit significant cytotoxic, DAT inhibitory, or neuroprotective activities [20-22]. Moreover, the 1,2,4 oxadiazole ring is a bioisoster of amides and esters and for this reason could improve bioavailability and physiochemical properties of compounds bearing it.

 

Continuing our search for new anticancer compounds [23-40], herein we report the synthesis of a new 1-methyl-3-[3-(1-methyl-1H-indol-3-yl)-1,2,4-oxadiazol-5-yl]-1H-pyrrolo[2,3-b]pyridine nortopsentin analog 1, designed on the basis of the potent activity shown by thiazole nortopsentin analogs with a 7-azaindole portion and considering the important characteristics of the 1,2,4-oxadiazole ring found in compounds with promising biological activity. The new compounds, in which the central imidazole ring of the natural lead was replaced by a 1,2,4-oxadiazole moiety, and in which a 7-azaindole portion substituted the original indole, were prescreened against the HCT-116 colon rectal carcinoma cell line and the two most active compounds were selected and further investigated in different human tumor cell lines.

 

2.Results and Discussion
2.1. Chemistry
1-Methyl-3-[3-(1-methyl-1H-indol-3-yl)-1,2,4-oxadiazol-5-yl]-1H-pyrrolo[2,3-b]pyridines 1 were synthesized by reaction between two different key intermediates, N'-hydroxy-1-methyl-1H-indole-3- carboximidamides 2 and methyl-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylates 3 (Scheme 1, Table 1).
N'-hydroxy-1-methyl-1H-indole-3-carboximidamides 2a-e, commercially unavailable, were synthesized from the corresponding 1-methyl-indoles of type 4, prepared as previously reported [16]. The reaction of compounds 4a-e with chlorosulfonyl isocyanate (CSI) in acetonitrile, followed by the addition of N,N-dimethylformamide (DMF), led to the corresponding carbonitriles 5a-e (90-98%), easily converted (65-82%) to the corresponding carboximidamides 2a-e through reaction with hydroxylamine hydrochloride in ethanol (EtOH), in the presence of diisopripylenethylamide (DIPEA).
Methyl-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylates 3a-c were in turn prepared from their 1-methyl-7-azaindoles 6a-c [10,16] converted into the corresponding 2,2,2-trichloro-1-(1-methyl- 1H-pyrrolo[2,3-b]pyridin-3-yl)ethanones 7a-c (80-99%) by reaction with trichloroacetyl chloride in dichloromethane (DCM) in the presence of aluminum chloride. Once obtained, compounds 7 were subjected to basic hydrolysis with potassium hydroxide solution (KOH 20%) to afford the desired derivatives 3 (90-99%).


2.2. Biology
In vitro cytotoxicity of the synthesized compounds 1a-o was prescreened against the HCT-116 colon sectal carcinoma cell line. Monolayer cultures treated for 72 h with 10-8-10-4c oncentrations of the comp ounds were examined by MTT assay for the cell viability.
Among the synthesized nortopsentin analogs, the compounds bearing the 5-bromo-1-methyl-1H- pyrrolo[2,3-b]pyridine moiety (see compounds 1k and 1n) showed the highest cytotoxic activity (Figure 1B). Substitution of the bromine atom in this portion with a fluorine (see compounds 1o and 1l) or absence o fthe halogen at om (see com pounds 1j and 1m) resulte d in a drop of the antiproliferative effect of the derivatives. The rem aining compounds appeared poorly effective.


The most active derivatives 1k and 1n were further investigated against MCF-7 (human breast cancer), HeLa (cervix adenocarcinoma), and CaCo2 (colorectal carcinoma) cell lines (Figure 2), and IC50 values in the micromolar and submicromolar range were calculated (Table 2). Compared to 1n, 1k derivative, with the exception of HeLa cell line, appeared 2-4-fold more effective.


Further studies on the mechanism of the cytotoxic activityof the active compoundswere carried out on MCF-7 cells, the tumor cell line more sensitive to both compounds. In order io investigate the effect on the cell cycle, flow cytometric analysis on PI stained MCF-7 cells was carried out after 24 h treatment with contpou nds 1k and 1n at their relevant IC50 values. As shown in Figure 3A, both the synthesized derivatives caused an accumulation of treated cells in subG0/G1 phase and induced their marked arrest (more than 60%) in G0-G1 phase of the cycle. Although changes in distribution within mitotic phases cannot provide precise information on the mechanism of drug's activity, those findings suggest that compounds 1k and 1n can affect the cell machinery promoting DNA duplication.
In order to assess the cell death mechanism, apoptosis induction caused by compounds 1k and 3n in MCF7 cells, after 24 h treatment, was investigated by means of Annexin V/PI dual staining method followed by cytofluorimetric analysis. The biparametric anolysis shonoed that both the compounds induced early ajtoptosis  without causing death by necrosis (Figure3B).


It is of interest to emphasize that other previously synthesized nortopsentin analogs bearing a 7-azaindole substitution and in which a thiazole ring substituted the central ring of the lead compound, showed cytotoxic activity towards MCF-7 cells associated with mitotic failure and accumulation of cells in phase G2/ M [12,16]. The substitution of the central ring with a 1,2,4 oxadiazole one provides molecules o7 different biological activity that leseoves to be investigated.
To further verify the pro-apoptotic effects of the synthesized derivatives, AO/EB staining was also used. Morphological evaluation of the cells using AO and EB double staining allows to detect early apoptotic cells stained green with yellow dots, with blebbing cytoplasm, while late apoptotic cells stain orange with fragmented nuclei, Non-apoptotic cells stain green. As shown in Figure 4, MCF-7 cells treated for 24 h with 1k or 1n showed morphological changes typical for early apoptosis withcondensationof nuclear material and formation of membrane blebbing.

Additional experiments were conducted on intestin al normal-like differentiated Caco-2 cell s. As shown in Figure 5, at the concentrations effective to inhibit the growth of tumor cells, the com pounds 1k and 1n did not affect to a large extent the viability of the norm al-like cells showing selectivity towards cancer cells (Figure 4).

Over 100,000 products now available from Angene:

CAS No. 113486-01-4

3,5-Heptadien-2-one, 6-phenyl-, (E,E)- (9CI)

Catalog No.:AG0008R9 MDL No.:

MF:C13H14O MW:186.2497

CAS No. 113486-29-6

2,4-Nonanedione, 3-methyl-

Catalog No.:AG0008R8 MDL No.:MFCD08741451

MF:C10H18O2 MW:170.2487

CAS No. 113486-30-9

2,4-Nonanedione, 3-propyl-

Catalog No.:AG0008R7 MDL No.:

MF:C12H22O2 MW:198.3019

CAS No. 113486-35-4

4H-1-Benzopyran-4-one, 2-(1-naphthalenyl)-

Catalog No.:AG0008R6 MDL No.:

MF:C19H12O2 MW:272.2974

CAS No. 113486-75-2

1,2,4-Triazolo[3,4-b][1,3,4]thiadiazol-6-amine, N,3-diphenyl-

Catalog No.:AG0008R5 MDL No.:

MF:C15H11N5S MW:293.3463

CAS No. 113486-92-3

6,6'-Bi-1,2,4-triazolo[3,4-b][1,3,4]thiadiazole, 3,3'-bis(4-methylphenyl)-

Catalog No.:AG0008R4 MDL No.:

MF:C20H14N8S2 MW:430.5088

CAS No. 113487-07-3

Ethanol, 2-[2-[[2-(2-hydroxyethoxy)decyl]thio]ethoxy]-

Catalog No.:AG0008R3 MDL No.:

MF:C16H34O4S MW:322.5038

CAS No. 113487-26-6

Phosphoric acid, diethyl 1-(tetrafluoroethylidene)heptyl ester (9CI)

Catalog No.:AG0008R2 MDL No.:

MF:C13H23F4O4P MW:350.2867

CAS No. 113487-28-8

3-Nonanone, 1,1,1,2-tetrafluoro-

Catalog No.:AG0008R1 MDL No.:

MF:C9H14F4O MW:214.2005

CAS No. 113487-29-9

4-Decanone, 1,1,1,2,2,3-hexafluoro-

Catalog No.:AG0008R0 MDL No.:

MF:C10H14F6O MW:264.2080

CAS No. 113487-35-7

2-Cyclohexen-1-one, 4,4-dimethyl-6-(trifluoromethyl)-

Catalog No.:AG0008QZ MDL No.:

MF:C9H11F3O MW:192.1782

CAS No. 113487-41-5

Thiocyanic acid, 2-fluorobutyl ester

Catalog No.:AG0008QY MDL No.:

MF:C5H8FNS MW:133.1871

CAS No. 113487-88-0

Ethanone, 1-(2-naphthalenyl)-2,2-diphenyl-

Catalog No.:AG0008QX MDL No.:

MF:C24H18O MW:322.3991

CAS No. 113493-52-0

Benzene, 1-(2-bromoethyl)-3-[[2-(trimethylsilyl)ethoxy]methoxy]-

Catalog No.:AG0008RY MDL No.:

MF:C14H23BrO2Si MW:331.3207

CAS No. 113493-60-0

2-Propanol, 1-(S-phenylsulfonimidoyl)- (9CI)

Catalog No.:AG0008RX MDL No.:

MF:C9H13NO2S MW:199.2700

CAS No. 113493-77-9

1-Propanone, 3-hydroxy-2,2-dimethyl-3-(4-methylphenyl)-1-phenyl-

Catalog No.:AG0008RW MDL No.:

MF:C18H20O2 MW:268.3502

CAS No. 113494-31-8

2,4-Pyrimidinediamine, 5-(3-chlorophenyl)-6-methyl-

Catalog No.:AG0008RV MDL No.:

MF:C11H11ClN4 MW:234.6848

CAS No. 113494-35-2

2,4-Pyrimidinediamine, 6-ethyl-5-(4-fluoro-3-nitrophenyl)-

Catalog No.:AG0008RU MDL No.:

MF:C12H12FN5O2 MW:277.2544

CAS No. 113494-43-2

2,4-Pyrimidinediamine, 5-(3-azido-4-fluorophenyl)-6-ethyl-

Catalog No.:AG0008RT MDL No.:

MF:C12H12FN7 MW:273.2690

CAS No. 113494-48-7

2,4-Pyrimidinediamine, 5-[4-chloro-3-(3,3-dimethyl-1-triazen-1-yl)phenyl]-6-ethyl-

Catalog No.:AG0008RS MDL No.:

MF:C14H18ClN7 MW:319.7926

CAS No. 113494-57-8

2,4-Quinazolinediamine, 6-azido-

Catalog No.:AG0008RR MDL No.:

MF:C8H7N7 MW:201.1881

CAS No. 113494-64-7

Phenol, 2-[1-heptyl-8-(3-hydroxyphenyl)octyl]-

Catalog No.:AG0008RQ MDL No.:

MF:C27H40O2 MW:396.6053

CAS No. 113494-65-8

Phosphine, ethylbis(1-methylethyl)-

Catalog No.:AG0008RP MDL No.:

MF:C8H19P MW:146.2102

CAS No. 113494-72-7

2H-Pyran-2-one, 6-(1-hydroxy-3-buten-1-yl)-4-methoxy-3,5-dimethyl-

Catalog No.:AG0008RO MDL No.:

MF:C12H16O4 MW:224.2530

CAS No. 113494-78-3

Propanal, 3-[(phenylmethoxy)methoxy]-

Catalog No.:AG0008RN MDL No.:

MF:C11H14O3 MW:194.2271

CAS No. 1134943-27-3

5H-Pyrrolo[3,2-b]pyridin-5-one, 1,4-dihydro-, hydrobromide (1:1)

Catalog No.:AG0008RA MDL No.:

MF:C7H7BrN2O MW:215.0473

CAS No. 113495-22-0

Ethanone, 1,1'-(2,4-selenophenediyl)bis- (9CI)

Catalog No.:AG0008RM MDL No.:

MF:C8H8O2Se MW:215.1079

CAS No. 113495-24-2

1,3-Propanediol, 1-(5,6-dihydro-2H-pyran-3-yl)-

Catalog No.:AG0008RL MDL No.:

MF:C8H14O3 MW:158.1950

CAS No. 113495-34-4

1,3-Dioxan-2-one, 4-ethenyl-

Catalog No.:AG0008RK MDL No.:

MF:C6H8O3 MW:128.1259

CAS No. 113495-45-7

2H-1,3-Benzoxazine, 4-chloro-2-methyl-

Catalog No.:AG0008RJ MDL No.:

MF:C9H8ClNO MW:181.6189

CAS No. 113495-49-1

Isoindolo[1,2-a]isoquinoline-8-carbonitrile

Catalog No.:AG0008RI MDL No.:

MF:C17H10N2 MW:242.2747

CAS No. 113495-60-6

Selenophene, 2,5-dihydro-3,4-diphenyl-

Catalog No.:AG0008RH MDL No.:

MF:C16H14Se MW:285.2424

CAS No. 113495-65-1

3,4-Selenophenediol, tetrahydro-2,5-dimethyl-3,4-diphenyl- (9CI)

Catalog No.:AG0008RG MDL No.:

MF:C18H20O2Se MW:347.3102

CAS No. 113495-70-8

Propanedioic acid, 2-(2-methyl-2,3-butadien-1-yl)-, 1,3-dimethyl ester

Catalog No.:AG0008RF MDL No.:

MF:C10H14O4 MW:198.2158

CAS No. 113496-12-1

Benzoic acid, 2-(2-methoxy-2-oxoethoxy)-

Catalog No.:AG0008RE MDL No.:MFCD11149408

MF:C10H10O5 MW:210.1834

CAS No. 113496-14-3

Benzeneacetic acid, 3-carboxy-, 1-methyl ester

Catalog No.:AG0008RD MDL No.:MFCD20640418

MF:C10H10O4 MW:194.1840

CAS No. 113496-17-6

Naphthalene, 2-(ethylsulfinyl)-

Catalog No.:AG0008RC MDL No.:

MF:C12H12OS MW:204.2881

CAS No. 113499-69-7

3(2H)-Benzofuranone, 5-[3-(4-phenyl-1-piperazinyl)propoxy]-

Catalog No.:AG0008RB MDL No.:

MF:C21H24N2O3 MW:352.4269

CAS No. 1135-00-8

Benzenesulfonamide, 4-butyl-

Catalog No.:AG0008SM MDL No.:MFCD00465202

MF:C10H15NO2S MW:213.2966

CAS No. 1135-05-3

Sulfamic acid, N,N-dimethyl-, 4-chlorophenyl ester

Catalog No.:AG0008SL MDL No.:

MF:C8H10ClNO3S MW:235.6879

CAS No. 1135-06-4

1-Aziridineethanamine, N,N-bis(1-aziridinylmethyl)-

Catalog No.:AG0008SK MDL No.:

MF:C10H20N4 MW:196.2926

CAS No. 1135-12-2

Benzenamine, 4-(phenylmethyl)-

Catalog No.:AG0008SJ MDL No.:MFCD00047861

MF:C13H13N MW:183.2490

CAS No. 1135-14-4

Benzenamine, 4-(phenylthio)-

Catalog No.:AG0008SI MDL No.:MFCD00094027

MF:C12H11NS MW:201.2874

CAS No. 1135-16-6

2-Propenoic acid, 3-(3-hydroxy-4-methoxyphenyl)-, (Z)- (9CI)

Catalog No.:AG0008SH MDL No.:

MF:C10H10O4 MW:194.1840

CAS No. 1135-21-3

Benzeneacetamide, N-(2-cyanoethyl)-

Catalog No.:AG0008SG MDL No.:

MF:C11H12N2O MW:188.2258

CAS No. 1135-24-6

2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-

Catalog No.:AG0008SF MDL No.:MFCD00004400

MF:C10H10O4 MW:194.1840

CAS No. 1135-31-5

Pyridazine, 3-(2-phenylethenyl)-

Catalog No.:AG0008SE MDL No.:

MF:C12H10N2 MW:182.2212

CAS No. 1135-34-8

Benzenamine, N-(phenylmethylene)-, hydrochloride (1:1)

Catalog No.:AG0008SD MDL No.:

MF:C13H12ClN MW:217.6941

CAS No. 1135-38-2

Butanoic acid, 3-(phenylmethoxy)-

Catalog No.:AG0008SC MDL No.:

MF:C11H14O3 MW:194.2271

CAS No. 1135-39-3

Butanoic acid, 3-hydroxy-, phenylmethyl ester

Catalog No.:AG0008SB MDL No.:

MF:C11H14O3 MW:194.2271

CAS No. 1135-40-6

1-Propanesulfonic acid, 3-(cyclohexylamino)-

Catalog No.:AG0008SA MDL No.:MFCD00003837

MF:C9H19NO3S MW:221.3171

CAS No. 1135-43-9

Ethanone, 1-[4-[[(methylamino)carbonyl]oxy]phenyl]-

Catalog No.:AG0008S9 MDL No.:

MF:C10H11NO3 MW:193.1992

CAS No. 1135-51-9

1,3,2-Dioxaborolane, 2,2'-[1,2-ethanediylbis(oxy)]bis-

Catalog No.:AG0008S8 MDL No.:

MF:C6H12B2O6 MW:201.7779

CAS No. 1135-58-6

Urea, N,N''-1,3-phenylenebis- (9CI)

Catalog No.:AG0008S7 MDL No.:

MF:C8H10N4O2 MW:194.1906

CAS No. 1135-61-1

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(2-methylpropyl)-

Catalog No.:AG0008S6 MDL No.:

MF:C10H16N2O3 MW:212.2456

CAS No. 1135-62-2

3,5-Piperidinedicarbonitrile, 4-ethyl-4-methyl-2,6-dioxo-

Catalog No.:AG0008S5 MDL No.:MFCD00023875

MF:C10H11N3O2 MW:205.2132

CAS No. 1135-63-3

1-Aziridineethanol, β-ethyl-β-methyl-α-phenyl-

Catalog No.:AG0008S4 MDL No.:

MF:C13H19NO MW:205.2961

CAS No. 1135-67-7

Cyclohexanecarboxylic acid, 1-phenyl-

Catalog No.:AG0008S3 MDL No.:MFCD00037152

MF:C13H16O2 MW:204.2649

CAS No. 1135-70-2

1,3-Dioxolane-4-methanol, 2-ethyl-2-phenyl-

Catalog No.:AG0008S2 MDL No.:

MF:C12H16O3 MW:208.2536

CAS No. 1135-72-4

Benzenemethanol, α-(1-hydroxycyclohexyl)-

Catalog No.:AG0008S1 MDL No.:

MF:C13H18O2 MW:206.2808

CAS No. 1135-98-4

Phosphinic fluoride, P,P-diphenyl-

Catalog No.:AG0008S0 MDL No.:

MF:C12H10FOP MW:220.1794

CAS No. 1135-99-5

Stannane, dichlorodiphenyl-

Catalog No.:AG0008RZ MDL No.:MFCD00000516

MF:C12H10Cl2Sn MW:343.8148

CAS No. 113500-35-9

Oxiranecarboxylic acid, 2,3-dimethyl-, 10-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-yl ester

Catalog No.:AG0008TB MDL No.:

MF:C21H22O8 MW:402.3946

CAS No. 113500-65-5

Benzenesulfonamide, N-[[4-(dimethylamino)phenyl]imino]-3-methyl-

Catalog No.:AG0008TA MDL No.:

MF:C15H17N3O2S MW:303.3794

CAS No. 113501-10-3

Oxirane, 2-butyl-3-ethenyl-, cis- (9CI)

Catalog No.:AG0008T9 MDL No.:

MF:C8H14O MW:126.1962

CAS No. 113501-26-1

Ethanamine, 2-(imidazo[1,2-b]pyridazin-6-ylthio)-N,N-dimethyl-

Catalog No.:AG0008T8 MDL No.:

MF:C10H14N4S MW:222.3100

CAS No. 113501-27-2

Imidazo[1,2-b]pyridazine, 6-fluoro-

Catalog No.:AG0008T7 MDL No.:MFCD11044764

MF:C6H4FN3 MW:137.1145

CAS No. 113501-43-2

2H-1,4-Benzoxazin-2-one, 7-(diethylamino)-3-methyl-

Catalog No.:AG0008T6 MDL No.:

MF:C13H16N2O2 MW:232.2783

CAS No. 113501-80-7

Benzoic acid, 2-[2-(2-hydroxy-3,5-dimethylphenyl)diazenyl]-

Catalog No.:AG0008T5 MDL No.:

MF:C15H14N2O3 MW:270.2833

CAS No. 113501-81-8

4-Thiazolidinone, 2-ethyl-2-methyl-

Catalog No.:AG0008T4 MDL No.:

MF:C6H11NOS MW:145.2226

CAS No. 113501-95-4

1H-Pyrazole, 3-methyl-1-octadecyl-

Catalog No.:AG0008T3 MDL No.:

MF:C22H42N2 MW:334.5823

CAS No. 113501-99-8

Benzenamine, 2-nitro-5-propoxy-

Catalog No.:AG0008T2 MDL No.:

MF:C9H12N2O3 MW:196.2032

CAS No. 113502-25-3

Urea, N-ethyl-N,N',N'-trimethyl-

Catalog No.:AG0008T1 MDL No.:

MF:C6H14N2O MW:130.1882

CAS No. 113502-26-4

4-Oxazolidinecarboxylic acid, 4-methyl-, 2-propen-1-yl ester

Catalog No.:AG0008T0 MDL No.:

MF:C8H13NO3 MW:171.1937

CAS No. 113502-34-4

1,3-Dithiolo[4,5-b][1,4]dithiin-2-thione, 5,6-bis(methylthio)-

Catalog No.:AG0008SZ MDL No.:

MF:C7H6S7 MW:314.5775

CAS No. 113502-46-8

1H-Pyrazole-4-carboxylic acid, 3-methyl-1-phenyl-, ethyl ester

Catalog No.:AG0008SY MDL No.:MFCD19103575

MF:C13H14N2O2 MW:230.2625

CAS No. 113502-50-4

1H-Pyrrole-1-acetic acid, 2-benzoyl-5-carboxy-

Catalog No.:AG0008SX MDL No.:

MF:C14H11NO5 MW:273.2408

CAS No. 113502-52-6

1H-Pyrrolizin-1-one, 5-benzoyl-2,3-dihydro-

Catalog No.:AG0008SW MDL No.:

MF:C14H11NO2 MW:225.2426

CAS No. 113502-55-9

Methanone, (2,3-dihydro-1H-pyrrolizin-5-yl)phenyl-

Catalog No.:AG0008SV MDL No.:

MF:C14H13NO MW:211.2591

CAS No. 113502-65-1

L-Tryptophanamide, L-phenylalanyl-L-methionyl-L-arginyl- (9CI)

Catalog No.:AG0008SU MDL No.:

MF:C31H43N9O4S MW:637.7960

CAS No. 113502-66-2

L-Leucinamide, L-phenylalanyl-L-methionyl-L-arginyl- (9CI)

Catalog No.:AG0008ST MDL No.:

MF:C26H44N8O4S MW:564.7438

CAS No. 113502-82-2

1,2-Benzenedicarboxylic acid, 1,2-bis[4-(butoxycarbonyl)phenyl] ester

Catalog No.:AG0008SS MDL No.:

MF:C30H30O8 MW:518.5544

CAS No. 113502-89-9

Benzaldehyde, 3-acetyl-4,6-bis(hexyloxy)-2-hydroxy-

Catalog No.:AG0008SR MDL No.:

MF:C21H32O5 MW:364.4758

CAS No. 113502-90-2

2-Butanone, 4-bromo-1-chloro-1-(phenylthio)-

Catalog No.:AG0008SQ MDL No.:

MF:C10H10BrClOS MW:293.6078

CAS No. 113502-96-8

2-Propanone, 1-(2,3-dihydro-5-methyl-2-furanyl)-

Catalog No.:AG0008SP MDL No.:

MF:C8H12O2 MW:140.1797

CAS No. 113503-25-6

Spiro[bicyclo[3.2.0]heptane-6,1'-cyclohexane]-2',7-dione

Catalog No.:AG0008SO MDL No.:

MF:C12H16O2 MW:192.2542

CAS No. 113503-45-0

2-Azabicyclo[3.2.2]nonan-3-one, 6,7,8,9-tetrakis(methylene)-

Catalog No.:AG0008TY MDL No.:

MF:C12H13NO MW:187.2377

CAS No. 113503-49-4

2-Oxabicyclo[3.2.2]nonan-3-one, 6,7,8,9-tetrakis(methylene)-

Catalog No.:AG0008TX MDL No.:

MF:C12H12O2 MW:188.2225

CAS No. 113503-65-4

Pyridine, 2-bromo-3-(1-methylethoxy)-

Catalog No.:AG0008TW MDL No.:

MF:C8H10BrNO MW:216.0751

CAS No. 1135032-28-8

Piperidine, 1-[3-(phenylmethoxy)phenyl]-

Catalog No.:AG0008TC MDL No.:MFCD23135707

MF:C18H21NO MW:267.3654

CAS No. 113504-54-4

Phosphonium, [3-(2,5-dioxo-1-pyrrolidinyl)propyl]triphenyl-, bromide (1:1)

Catalog No.:AG0008TV MDL No.:

MF:C25H25BrNO2P MW:482.3493

CAS No. 113504-68-0

2-Naphthalenol, 7-(di-2-propen-1-ylamino)-5,6,7,8-tetrahydro-

Catalog No.:AG0008TU MDL No.:

MF:C16H21NO MW:243.3440

CAS No. 113504-83-9

Adenosine, N-benzoyl-2'-deoxy-5'-O-[tris(4-methoxyphenyl)methyl]- (9CI)

Catalog No.:AG0008TT MDL No.:

MF:C39H37N5O7 MW:687.7404

CAS No. 113504-85-1

1H-Imidazole, 5-[(2,5-dimethylphenyl)methyl]-

Catalog No.:AG0008TS MDL No.:

MF:C12H14N2 MW:186.2530

CAS No. 113504-86-2

1H-Imidazole, 5-(2,6-dimethylphenyl)-

Catalog No.:AG0008TR MDL No.:

MF:C11H12N2 MW:172.2264

CAS No. 113504-93-1

1,3-Benzodioxole, 5-isothiocyanato-

Catalog No.:AG0008TQ MDL No.:MFCD00066321

MF:C8H5NO2S MW:179.1958

CAS No. 113504-97-5

Benzoic acid, 4-chloro-, 2-bromopropyl ester

Catalog No.:AG0008TP MDL No.:

MF:C10H10BrClO2 MW:277.5422

CAS No. 113505-01-4

Furan, 2-[[(2-methyl-2-propen-1-yl)oxy]methyl]-

Catalog No.:AG0008TO MDL No.:

MF:C9H12O2 MW:152.1904

CAS No. 113505-02-5

Furan, 2-[(1-propen-1-yloxy)methyl]-

Catalog No.:AG0008TN MDL No.:

MF:C8H10O2 MW:138.1638

CAS No. 113505-06-9

Benzenamine, 4,4'-(2,3-dihydro-1H-inden-1-ylidene)bis-

Catalog No.:AG0008TM MDL No.:

MF:C21H20N2 MW:300.3969

CAS No. 113505-07-0

Benzenamine, 4,4'-(3,4-dihydro-1(2H)-naphthalenylidene)bis- (9CI)

Catalog No.:AG0008TL MDL No.:

MF:C22H22N2 MW:314.4235

CAS No. 113505-10-5

Hexanamide, N,N-bis(4-hydroxybutyl)-

Catalog No.:AG0008TK MDL No.:

MF:C14H29NO3 MW:259.3850

CAS No. 113505-74-1

1,3-Dioxan-4-one, 2-(1,1-dimethylethyl)-6-methyl-5-(phenylseleno)-

Catalog No.:AG0008TJ MDL No.:

MF:C15H20O3Se MW:327.2775

CAS No. 113506-37-9

2-Propenoic acid, 2-methyl-, 3,3-dichloro-2,2,3-trifluoropropyl ester

Catalog No.:AG0008TI MDL No.:

MF:C7H7Cl2F3O2 MW:251.0305

CAS No. 113507-78-1

Ethanesulfonic acid, 1,1,2,2-tetrafluoro-2-(2,2,2-trifluoroethoxy)-

Catalog No.:AG0008TH MDL No.:

MF:C4H3F7O4S MW:280.1180

CAS No. 113507-82-7

Ethanesulfonic acid, 1,1,2,2-tetrafluoro-2-(1,1,2,2,2-pentafluoroethoxy)-

Catalog No.:AG0008TG MDL No.:MFCD00153237

MF:C4HF9O4S MW:316.0990

CAS No. 113507-84-9

Ethanesulfonic acid, 2,2'-oxybis[1,1,2,2-tetrafluoro-

Catalog No.:AG0008TF MDL No.:

MF:C4H2F8O7S2 MW:378.1717

CAS No. 113508-10-4

2-Quinolinamine, 4-(methylthio)-

Catalog No.:AG0008TE MDL No.:

MF:C10H10N2S MW:190.2648

CAS No. 113508-12-6

2-Quinolinamine, 7-(trifluoromethyl)-

Catalog No.:AG0008TD MDL No.:

MF:C10H7F3N2 MW:212.1712

CAS No. 1135124-02-5

Thieno[2,3-c]pyridine-2,6(5H)-dicarboxylic acid, 4,7-dihydro-, 6-(1,1-dimethylethyl) 2-ethyl ester

Catalog No.:AG0008U0 MDL No.:MFCD23135786

MF:C15H21NO4S MW:311.3965

CAS No. 128014-09-5

Phosphinic bromide, P-(1,1-dimethylethyl)-P-phenyl-

Catalog No.:AG0008SN MDL No.:

MF:C10H14BrOP MW:261.0953

© 2019 Angene International Limited. All rights Reserved.